AAAAAA
Results: 1-25/59
Authors:
EVANS W
PIPPENGER N
Citation: W. Evans et N. Pippenger, AVERAGE-CASE LOWER BOUNDS FOR NOISY BOOLEAN DECISION TREES, SIAM journal on computing (Print), 28(2), 1999, pp. 433-446
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
MESSINGER Y
YANISHEVSKI Y
EK O
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
Authors:
MESSINGER Y
YANISHEVSKI Y
EK O
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
Authors:
MOORE TJ
EVANS W
MURRAY D
Citation: Tj. Moore et al., OPERATIVE MANAGEMENT OF FOOT AND ANKLE EQUINOVARUS ASSOCIATED WITH FOCAL DYSTONIA, Foot & ankle international, 19(4), 1998, pp. 229-231
Authors:
EK O
YANISHEVSKI Y
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: O. Ek et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE, Leukemia & lymphoma, 30(3-4), 1998, pp. 389-394
Authors:
EVANS W
Citation: W. Evans, BIBLIOGRAPHY, Public understanding of science, 7(3), 1998, pp. 263-266
Authors:
EVANS W
Citation: W. Evans, BIBLIOGRAPHY, Public understanding of science, 7(2), 1998, pp. 199-202
Authors:
HAYES MW
OUVRIER RA
EVANS W
SOMERVILLE E
MORRIS JGL
Citation: Mw. Hayes et al., X-LINKED DYSTONIA-DEAFNESS SYNDROME, Movement disorders, 13(2), 1998, pp. 303-308
Authors:
EVANS W
PHERNETTON TM
MAGNESS RR
Citation: W. Evans et al., 17-BETA-ESTRADIOL EFFECT ON CRITICAL CARDIAC-OUTPUT WITH REDUCTION OFCARDIAC-OUTPUT IN OOPHORECTOMIZED SHEEP, American journal of physiology. Heart and circulatory physiology, 44(1), 1998, pp. 57-64
Authors:
PIKOULAKIS EV
EVANS W
Citation: Ev. Pikoulakis et W. Evans, STAGGERING, THE OPTIMAL MONETARY RULE AND PERSISTENCE, Economics letters, 59(1), 1998, pp. 91-95
Authors:
MASON WA
ZIMMERMAN L
EVANS W
Citation: Wa. Mason et al., SEXUAL AND PHYSICAL ABUSE AMONG INCARCERATED YOUTH - IMPLICATIONS FORSEXUAL-BEHAVIOR, CONTRACEPTIVE USE, AND TEENAGE PREGNANCY, Child abuse & neglect, 22(10), 1998, pp. 987-995
Authors:
EVANS W
PIPPENGER N
Citation: W. Evans et N. Pippenger, ON THE MAXIMUM TOLERABLE NOISE FOR RELIABLE COMPUTATION BY FORMULAS, IEEE transactions on information theory, 44(3), 1998, pp. 1299-1305
Authors:
HOEG JM
KAUFFMAN RD
HERDERICK E
DEMOSKY SJ
EVANS W
BROUSSEAU ME
Citation: Jm. Hoeg et al., LECITHIN-CHOLESTEROL ACYL TRANSFERASE REQUIRES FUNCTIONAL LDL RECEPTORS TO PREVENT ATHEROSCLEROSIS, Circulation, 98(17), 1998, pp. 2444-2444
Authors:
ERNST J
EVANS W
FRASER CW
LUCCO S
PROEBSTING TA
Citation: J. Ernst et al., CODE COMPRESSION, ACM SIGPLAN NOTICES, 32(5), 1997, pp. 358-365
Authors:
UCKUN FM
YANISHEVSKI Y
TUMER N
WAURZYNIAK B
MESSINGER Y
CHELSTROM LM
LISOWSKI EA
EK O
ZEREN T
WENDORF H
LANGLIE MC
IRVIN JD
MYERS DE
FULLER GB
EVANS W
GUNTHER R
Citation: Fm. Uckun et al., PHARMACOKINETIC FEATURES, IMMUNOGENICITY, AND TOXICITY OF B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN CYNOMOLGUS MONKEYS, Clinical cancer research, 3(3), 1997, pp. 325-337
Authors:
PAMPHLETT R
LEVINGSTON R
EVANS W
BLACKIE J
Citation: R. Pamphlett et al., VARYING NEUROPATHOLOGICAL FEATURES IN FAMILIAL PROGRESSIVE SUPRANUCLEAR PALSY, Brain pathology, 7(4), 1997, pp. 1112-1112
Authors:
JONES MZ
ALROY J
MITCHELLHERPOISHEIMER C
ARIAS A
SILLENCE D
EVANS W
ALVORD EC
RUTLEDGE JC
SHARP P
HOPWOOD JJ
Citation: Mz. Jones et al., HUMAN AND CAPRINE MPS III-D PATHOGENESIS OF CNS DYSFUNCTION, Brain pathology, 7(4), 1997, pp. 1280-1280
Authors:
KENDALL E
EVANS W
JIN H
HOLLAND L
VETRIE D
Citation: E. Kendall et al., A COMPLETE YAC CONTIG AND COSMID INTERVAL MAP COVERING THE ENTIRETY OF HUMAN XQ21.33 TO XQ22.3 FROM DXS3 TO DXS287, Genomics, 43(2), 1997, pp. 171-182
Authors:
EVANS C
PETITT R
EVANS W
WOODHEAD SJ
PETERS JR
HAMPSON G
Citation: C. Evans et al., CALCIUM VITAMIN-D AND BONE METABOLISM IN DIABETES-MELLITUS - A CROSS-SECTIONAL STUDY, Journal of bone and mineral research, 12, 1997, pp. 651-651
Authors:
EVANS W
MORGAN M
JOHNSON I
BALTUTIS L
Citation: W. Evans et al., OCCLUSAL CARIES DIAGNOSIS AND TREATMENT, Australian dental journal, 42(4), 1997, pp. 269-270
Authors:
EVANS W
Citation: W. Evans, FUNCTIONAL AND METABOLIC CONSEQUENCES OF SARCOPENIA, The Journal of nutrition, 127, 1997, pp. 998-1003
Authors:
JONES MZ
ALROY J
RUTLEDGE JC
TAYLOR JW
ALVORD EC
TOONE J
APPLEGARTH D
HOPWOOD JJ
SKUTELSKY E
IANELLI C
THORLEYLAWSON D
MITCHELLHERPOLSHEIMER C
ARIAS A
SHARP P
EVANS W
SILLENCE D
CAVANAGH KT
Citation: Mz. Jones et al., HUMAN MUCOPOLYSACCHARIDOSIS-IIID - CLINICAL, BIOCHEMICAL, MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS, Journal of neuropathology and experimental neurology, 56(10), 1997, pp. 1158-1167
Authors:
EVANS W
Citation: W. Evans, MORE DEPTH AND LESS BREADTH, Chemistry in Britain, 33(10), 1997, pp. 22-22